Is myopathy a side effect of ITRACONAZOLE ? ( FactMed.com )

About this FactMed analysis covering adverse side effect reports of ITRACONAZOLE patients who developed myopathy.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 51 individuals taking ITRACONAZOLE reported myopathy to the FDA. A total of 4412 ITRACONAZOLE drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between ITRACONAZOLE and myopathy. In doing so, we compare ITRACONAZOLE with other drugs that cause myopathy, to help you evaluate whether or not ITRACONAZOLE causes myopathy. Likewise, this page shows the most highly-reported side effects of ITRACONAZOLE, so you can see if myopathy ranks among ITRACONAZOLE's most well-known side effects.

Summary Statistics
Reports of ITRACONAZOLE causing myopathy: 51
Reports of any side effect of ITRACONAZOLE : 4412
Percentage of ITRACONAZOLE patients where myopathy is a reported side effect: 1.1559%

FDA reports of any drug causing myopathy : 3605
Average percentage for all medicated patients where myopathy is reported as a complication: 0.0226%

Physician opinion on ITRACONAZOLE as adverse event culprit:

Overall opinion for all reports of this drug:

Most frequent diagnoses/indications for prescribing ITRACONAZOLE:

PROPHYLAXIS ( 344 patients )
ANTIFUNGAL PROPHYLAXIS ( 301 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 200 patients )
DRUG USE FOR UNKNOWN INDICATION ( 174 patients )
ONYCHOMYCOSIS ( 169 patients )
BRONCHOPULMONARY ASPERGILLOSIS ( 141 patients )
INFECTION PROPHYLAXIS ( 130 patients )
FUNGAL INFECTION ( 106 patients )
ASPERGILLOSIS ( 81 patients )
HISTOPLASMOSIS ( 42 patients )
BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC ( 38 patients )
ORAL CANDIDIASIS ( 37 patients )
NAIL TINEA ( 33 patients )
SYSTEMIC MYCOSIS ( 28 patients )
CANDIDIASIS ( 26 patients )
ASPERGILLOMA ( 26 patients )
OESOPHAGEAL CANDIDIASIS ( 21 patients )
TINEA PEDIS ( 18 patients )
PULMONARY MYCOSIS ( 17 patients )
HISTOPLASMOSIS DISSEMINATED ( 17 patients )
ANTIFUNGAL TREATMENT ( 14 patients )
SYSTEMIC CANDIDA ( 13 patients )
KERATITIS FUNGAL ( 13 patients )
ILL-DEFINED DISORDER ( 13 patients )
INFECTION ( 13 patients )
PARACOCCIDIOIDES INFECTION ( 11 patients )
FUNGAL SKIN INFECTION ( 11 patients )
MUCOSAL INFLAMMATION ( 10 patients )
PNEUMONIA ( 10 patients )
BLASTOMYCOSIS ( 10 patients )
PREMEDICATION ( 8 patients )
CRYPTOCOCCOSIS ( 8 patients )
PULMONARY NECROSIS ( 8 patients )
PNEUMONIA FUNGAL ( 8 patients )
FEBRILE NEUTROPENIA ( 7 patients )
CYSTIC FIBROSIS ( 7 patients )
DRUG EXPOSURE DURING PREGNANCY ( 7 patients )
FUNGAEMIA ( 6 patients )
PHAEHYPHOMYCOSIS ( 6 patients )
TINEA INFECTION ( 5 patients )
LUNG INFECTION ( 5 patients )
ALTERNARIA INFECTION ( 5 patients )
COCCIDIOIDOMYCOSIS ( 5 patients )
DERMATOPHYTOSIS ( 5 patients )
ACUTE PROMYELOCYTIC LEUKAEMIA ( 5 patients )
BODY TINEA ( 5 patients )
VULVOVAGINAL MYCOTIC INFECTION ( 4 patients )
OBLITERATIVE BRONCHIOLITIS ( 4 patients )
VULVOVAGINAL CANDIDIASIS ( 4 patients )
PULMONARY GRANULOMA ( 4 patients )
STOMATITIS ( 4 patients )
BRONCHIAL SECRETION RETENTION ( 4 patients )
SCEDOSPORIUM INFECTION ( 4 patients )
ANTI-INFECTIVE THERAPY ( 4 patients )
PANCYTOPENIA ( 4 patients )
EYE INFECTION FUNGAL ( 3 patients )
ANTIBIOTIC THERAPY ( 3 patients )
MULTIPLE MYELOMA ( 3 patients )
PNEUMONIA CRYPTOCOCCAL ( 3 patients )
ACUTE MYELOID LEUKAEMIA ( 3 patients )
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE ( 3 patients )
SINUSITIS FUNGAL ( 3 patients )
BREAST CANCER ( 3 patients )
ACANTHAMOEBA KERATITIS ( 3 patients )
PYREXIA ( 3 patients )
DERMATITIS ( 3 patients )
ACUTE LYMPHOCYTIC LEUKAEMIA ( 3 patients )
URINARY TRACT INFECTION ( 3 patients )
BONE MARROW TRANSPLANT ( 2 patients )
PENICILLIOSIS ( 2 patients )
BREAST CANCER METASTATIC ( 2 patients )
PHARYNGITIS ( 2 patients )
FUNGAL PERITONITIS ( 2 patients )
PULMONARY SARCOIDOSIS ( 2 patients )
CYSTIC FIBROSIS LUNG ( 2 patients )
PNEUMONIA ASPERGILLUS ( 2 patients )
ACUTE LEUKAEMIA ( 2 patients )
CANDIDA PNEUMONIA ( 2 patients )
FUNGUS CULTURE POSITIVE ( 2 patients )
RENAL FAILURE ( 2 patients )
TINEA VERSICOLOUR ( 2 patients )
RESPIRATORY MONILIASIS ( 2 patients )
ASTHMA ( 2 patients )
RESPIRATORY TRACT INFECTION FUNGAL ( 2 patients )
BEZOAR ( 2 patients )
ALLERGY TEST ( 2 patients )
OSTEOMYELITIS FUNGAL ( 2 patients )
MENINGITIS CRYPTOCOCCAL ( 2 patients )
HIV TEST POSITIVE ( 2 patients )
NEPHRITIS ( 2 patients )
PNEUMONIA BACTERIAL ( 2 patients )
GLOSSITIS ( 2 patients )
TRANSPLANT ( 2 patients )
ATYPICAL MYCOBACTERIAL INFECTION ( 2 patients )
CHEMOTHERAPY ( 2 patients )
CHRONIC GRANULOMATOUS DISEASE ( 2 patients )
EVIDENCE BASED TREATMENT ( 2 patients )
CHRONIC PULMONARY HISTOPLASMOSIS ( 2 patients )
SPOROTRICHOSIS ( 2 patients )
MUCOCUTANEOUS CANDIDIASIS ( 1 patients )
PSORIASIS ( 1 patients )
CONJUNCTIVITIS INFECTIVE ( 1 patients )
HIV INFECTION CDC GROUP IV SUBGROUP E ( 1 patients )
STEM CELL TRANSPLANT ( 1 patients )
CUTANEOUS SPOROTRICHOSIS ( 1 patients )
HYPERLIPIDAEMIA ( 1 patients )
APLASTIC ANAEMIA ( 1 patients )
IMMUNOSUPPRESSANT DRUG THERAPY ( 1 patients )
DERMATITIS ATOPIC ( 1 patients )
GRAFT VERSUS HOST DISEASE ( 1 patients )
DIFFUSE LARGE B-CELL LYMPHOMA ( 1 patients )
INTRANASAL FUNGAL INFECTION ( 1 patients )
TREATMENT NONCOMPLIANCE ( 1 patients )
ACUTE PULMONARY HISTOPLASMOSIS ( 1 patients )
CELLULITIS ( 1 patients )
GRANULOMA ( 1 patients )
PROPHYLACTIC CHEMOTHERAPY ( 1 patients )
TUBERCULOSIS ( 1 patients )
CHROMOBLASTOMYCOSIS ( 1 patients )
HERPES ZOSTER ( 1 patients )
SEPSIS ( 1 patients )
BLOOD CULTURE POSITIVE ( 1 patients )
ENDOCARDITIS ( 1 patients )
VAGINAL DISCHARGE ( 1 patients )
CHRONIC OBSTRUCTIVE PULMONARY DISEASE ( 1 patients )
BONE MARROW CONDITIONING REGIMEN ( 1 patients )
EXANTHEM ( 1 patients )
PROSTATE CANCER ( 1 patients )
ANTIBIOTIC PROPHYLAXIS ( 1 patients )
HIV INFECTION ( 1 patients )
SPUTUM CULTURE POSITIVE ( 1 patients )
MYELODYSPLASTIC SYNDROME ( 1 patients )
ANTIVIRAL PROPHYLAXIS ( 1 patients )
CANDIDA SEPSIS ( 1 patients )
OCHRONOSIS ( 1 patients )
RESPIRATORY DISORDER ( 1 patients )
ASPERGILLUS TEST POSITIVE ( 1 patients )
INTERSTITIAL LUNG DISEASE ( 1 patients )
CATHETER SEPSIS ( 1 patients )
GRANULOCYTOPENIA ( 1 patients )
OESOPHAGEAL PAIN ( 1 patients )
RESPIRATORY TRACT INFECTION ( 1 patients )
IRON OVERLOAD ( 1 patients )
TRICHOSPORON INFECTION ( 1 patients )
ADVERSE EVENT ( 1 patients )
HEPATIC FUNCTION ABNORMAL ( 1 patients )
OPPORTUNISTIC INFECTION PROPHYLAXIS ( 1 patients )
ECZEMA ( 1 patients )
LUNG DISORDER ( 1 patients )
ALLOGENIC BONE MARROW TRANSPLANTATION THERAPY ( 1 patients )
HISTIOCYTOSIS HAEMATOPHAGIC ( 1 patients )
ORAL FUNGAL INFECTION ( 1 patients )
SINUSITIS ASPERGILLUS ( 1 patients )
LYMPHOMA ( 1 patients )
PROPHYLAXIS AGAINST TRANSPLANT REJECTION ( 1 patients )
VAGINAL MYCOSIS ( 1 patients )
( 0 patients )

Drugs with high FDA adverse event association with myopathy:

LIPITOR (517 patients)
ZOCOR (480 patients)
ASPIRIN (474 patients)
SIMVASTATIN (410 patients)
FOSAMAX (309 patients)
PREDNISONE (241 patients)
CRESTOR (239 patients)
ZOMETA (201 patients)
PREDNISOLONE (199 patients)
LASIX (177 patients)
FUROSEMIDE (162 patients)
ZETIA (153 patients)
HYDROCHLOROTHIAZIDE (144 patients)
PREDNISONE TAB (139 patients)
LEVOTHYROXINE SODIUM (138 patients)
VIOXX (130 patients)
ALLOPURINOL (125 patients)
DEXAMETHASONE (124 patients)
INSULIN (120 patients)
COUMADIN (118 patients)
CYCLOSPORINE (113 patients)
ATENOLOL (112 patients)
ATORVASTATIN CALCIUM (110 patients)
NORVASC (108 patients)
CLARITHROMYCIN (107 patients)
AMBIEN (104 patients)
MYCOPHENOLATE MOFETIL (103 patients)
LISINOPRIL (99 patients)
NOROXIN (98 patients)
DECADRON (97 patients)
OMEPRAZOLE (97 patients)
POTASSIUM CHLORIDE (96 patients)
SORAFENIB (RAF KINASE INHIBITOR) (95 patients)
GABAPENTIN (94 patients)
SYNTHROID (94 patients)
LAMIVUDINE (90 patients)
AMLODIPINE (90 patients)
RAMIPRIL (89 patients)
NEXIUM (88 patients)
PRILOSEC (87 patients)
METHYLPREDNISOLONE (85 patients)
WARFARIN SODIUM (83 patients)
ZIDOVUDINE (82 patients)
ALBUTEROL (82 patients)
LANSOPRAZOLE (80 patients)
MEK INHIBITOR (DIHYDROXYPROP-DIFLU-METHOXYPHEN-CYCLOPROPA-SULFAMI) (80 patients)
PROTONIX (79 patients)
ACETAMINOPHEN (77 patients)
FOLIC ACID (77 patients)
MULTI-VITAMINS (75 patients)
XANAX (75 patients)
COZAAR (73 patients)
NEURONTIN (73 patients)
REMICADE (71 patients)
REVLIMID (69 patients)
HUMIRA (68 patients)
AMIODARONE HCL (67 patients)
FLONASE (65 patients)
CELEXA (64 patients)
FERROUS SULFATE TAB (64 patients)
ATORVASTATIN (64 patients)
AMLODIPINE BESYLATE (64 patients)
SPIRONOLACTONE (63 patients)
MAGNEVIST (62 patients)
VYTORIN (62 patients)
ZOLOFT (61 patients)
PEPCID (60 patients)
PROGRAF (60 patients)
CITALOPRAM HYDROBROMIDE (59 patients)
VICODIN (59 patients)
ADVAIR DISKUS 100/50 (59 patients)
ULTRAVIST 150 (59 patients)
PLAVIX (59 patients)
METHOTREXATE (58 patients)
COLCHICINE (58 patients)
AREDIA (57 patients)
OXYCONTIN (57 patients)
LYRICA (57 patients)
DIDANOSINE (56 patients)
ENALAPRIL MALEATE (55 patients)
HEPARIN SODIUM INJECTION (55 patients)
TAMOXIFEN CITRATE (55 patients)
ACYCLOVIR (52 patients)
FENOFIBRATE (52 patients)
PRAVASTATIN (52 patients)
CLONAZEPAM (51 patients)
ITRACONAZOLE (51 patients)
CYCLOPHOSPHAMIDE (51 patients)
DIGOXIN (49 patients)
SEBIVO (49 patients)
TOPROL-XL (49 patients)
LORAZEPAM (48 patients)
DILTIAZEM (48 patients)
LORTAB (48 patients)
ELAVIL (47 patients)
DIFLUCAN (47 patients)
METOPROLOL TARTRATE (46 patients)
ATIVAN (46 patients)
VELCADE (45 patients)
ALENDRONATE SODIUM (45 patients)
VITAMIN D (45 patients)
KLOR-CON (45 patients)
PRAVACHOL (45 patients)
WELLBUTRIN (44 patients)
TRICOR (44 patients)
DARVOCET-N 100 (44 patients)
PERCOCET (44 patients)
RAPAMUNE (43 patients)
ASCORBIC ACID (43 patients)
LEVAQUIN (43 patients)
AROMASIN (43 patients)
DIAZEPAM (43 patients)
ZANTAC (43 patients)
GEMFIBROZIL (41 patients)
CELEBREX (41 patients)
OXYCODONE HCL (41 patients)
ABACAVIR (40 patients)
LEXAPRO (40 patients)
NIFEDIPINE (40 patients)
RADIATION THERAPY (39 patients)
ACETYLSALICYLIC ACID SRT (39 patients)
ACIPHEX (39 patients)
METFORMIN HCL (39 patients)
IRON (39 patients)
ALTACE (39 patients)
TACROLIMUS (38 patients)
EFAVIRENZ (38 patients)
ZYPREXA (38 patients)
ZYRTEC (38 patients)
LESCOL (37 patients)
[THERAPY UNSPECIFIED] (37 patients)
METOPROLOL (37 patients)
GLEEVEC (37 patients)
PANTOPRAZOLE SODIUM (36 patients)
FOSAMAX PLUS D (36 patients)
PROPRANOLOL HYDROCHLORIDE (36 patients)
EFFEXOR (36 patients)
AMIODARONE (36 patients)
CEFTRIAXONE (36 patients)
HERCEPTIN (35 patients)
THALIDOMIDE (35 patients)
FUSIDIC ACID (35 patients)
SINGULAIR (35 patients)
IBUPROFEN (35 patients)
SPIRIVA (35 patients)
LOSARTAN POTASSIUM (35 patients)
VANCOMYCIN (35 patients)
WARFARIN (34 patients)
PERIDEX (34 patients)
BISOPROLOL (34 patients)
HYZAAR (34 patients)
SIROLIMUS (34 patients)
SOLU-MEDROL (34 patients)
ALPRAZOLAM (34 patients)
CO-TRIMOXAZOLE (34 patients)
AMITRIPTYLINE HCL (34 patients)
COREG (34 patients)
VITAMINS (UNSPECIFIED) (33 patients)
ACETYLSALICYLIC ACID (33 patients)
AZATHIOPRINE (33 patients)
ZOFRAN (33 patients)
CALTRATE +D (33 patients)
PROTEINASE INHIBITORS (33 patients)
CARTIA /USA/ (33 patients)
NIASPAN (33 patients)
PANTOPRAZOLE (33 patients)
MEGESTROL ACETATE (32 patients)
COMPAZINE (32 patients)
ADENOSINE (32 patients)
ALDACTONE (32 patients)
LANTUS (32 patients)
GASMOTIN (32 patients)
PROZAC (32 patients)
ARIMIDEX (31 patients)
AVELOX (31 patients)
FENTANYL (31 patients)
CALCIUM (UNSPECIFIED) (31 patients)
PAXIL (31 patients)
GLIPIZIDE (31 patients)
FLUCONAZOLE (31 patients)
ARANESP (31 patients)
CLARITIN (31 patients)
DILAUDID (31 patients)
NEUPOGEN (31 patients)
AVANDIA (31 patients)
B12 ^RECIP^ (30 patients)
K-DUR (30 patients)
CALCIUM CARBONATE (30 patients)
CELLCEPT (30 patients)
METFORMIN (30 patients)
CLOPIDOGREL (30 patients)
TRAMADOL HCL (30 patients)
REQUIP (29 patients)
CARVEDILOL (29 patients)
GLUCOPHAGE (29 patients)
FLOMAX (29 patients)
ZESTRIL (29 patients)
MIRTAZAPINE (29 patients)
TIAZAC (29 patients)
CAPECITABINE (29 patients)
KETEK (29 patients)
NICORANDIL (29 patients)
VERAPAMIL (29 patients)
CYMBALTA (28 patients)
RALTEGRAVIR (28 patients)
LOVASTATIN (28 patients)
CALCIUM (28 patients)
ACTOS (28 patients)
MICARDIS (28 patients)
DILTIAZEM HYDROCHLORIDE (28 patients)

Most common side effects for patients taking ITRACONAZOLE:

DRUG INTERACTION (413 patients)
PYREXIA (368 patients)
PNEUMONIA (296 patients)
PLATELET COUNT DECREASED (289 patients)
DRUG INEFFECTIVE (283 patients)
FEBRILE NEUTROPENIA (239 patients)
DIARRHOEA (209 patients)
RENAL IMPAIRMENT (208 patients)
WHITE BLOOD CELL COUNT DECREASED (203 patients)
SEPSIS (200 patients)
NEUTROPENIA (198 patients)
ANAEMIA (196 patients)
NAUSEA (173 patients)
HEPATIC FUNCTION ABNORMAL (170 patients)
HYPOKALAEMIA (166 patients)
NEUTROPHIL COUNT DECREASED (153 patients)
PLEURAL EFFUSION (153 patients)
THROMBOCYTOPENIA (150 patients)
RESPIRATORY FAILURE (143 patients)
ALANINE AMINOTRANSFERASE INCREASED (139 patients)
BRONCHOPULMONARY ASPERGILLOSIS (131 patients)
DYSPNOEA (129 patients)
PANCYTOPENIA (129 patients)
DISSEMINATED INTRAVASCULAR COAGULATION (123 patients)
OEDEMA PERIPHERAL (121 patients)
INTERSTITIAL LUNG DISEASE (120 patients)
MULTI-ORGAN FAILURE (116 patients)
LIVER DISORDER (113 patients)
RENAL FAILURE (112 patients)
DISEASE PROGRESSION (112 patients)
RENAL FAILURE ACUTE (104 patients)
VOMITING (104 patients)
BLOOD LACTATE DEHYDROGENASE INCREASED (103 patients)
INFECTION (103 patients)
HYPONATRAEMIA (101 patients)
MALAISE (101 patients)
ASPARTATE AMINOTRANSFERASE INCREASED (101 patients)
CONDITION AGGRAVATED (99 patients)
CYTOMEGALOVIRUS INFECTION (94 patients)
ACUTE GRAFT VERSUS HOST DISEASE (91 patients)
NEUROPATHY PERIPHERAL (90 patients)
CONVULSION (86 patients)
RASH (86 patients)
ASPERGILLOSIS (86 patients)
FATIGUE (83 patients)
HAEMOGLOBIN DECREASED (83 patients)
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN (82 patients)
FUNGAL INFECTION (82 patients)
CONSTIPATION (81 patients)
HYPOTENSION (80 patients)
C-REACTIVE PROTEIN INCREASED (78 patients)
SEPTIC SHOCK (78 patients)
ABDOMINAL PAIN (77 patients)
ASTHENIA (74 patients)
MYALGIA (73 patients)
BLOOD BILIRUBIN INCREASED (73 patients)
DEATH (71 patients)
BLOOD ALKALINE PHOSPHATASE INCREASED (70 patients)
BLOOD CREATININE INCREASED (70 patients)
CARDIAC FAILURE (69 patients)
OEDEMA (68 patients)
CELLULITIS (66 patients)
HYPERTENSION (65 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (63 patients)
GRAFT VERSUS HOST DISEASE (63 patients)
RHABDOMYOLYSIS (62 patients)
DRUG RESISTANCE (62 patients)
HEADACHE (61 patients)
BLOOD CREATINE PHOSPHOKINASE INCREASED (60 patients)
STAPHYLOCOCCAL INFECTION (59 patients)
ILEUS PARALYTIC (59 patients)
HERPES ZOSTER (59 patients)
GASTROINTESTINAL HAEMORRHAGE (59 patients)
TREMOR (59 patients)
LIVER FUNCTION TEST ABNORMAL (59 patients)
DECREASED APPETITE (56 patients)
DRUG LEVEL INCREASED (55 patients)
HAEMOPTYSIS (54 patients)
GAMMA-GLUTAMYLTRANSFERASE INCREASED (53 patients)
HEPATIC FAILURE (53 patients)
COUGH (52 patients)
MYOPATHY (51 patients)
ACUTE MYELOID LEUKAEMIA (51 patients)
STOMATITIS (51 patients)
BONE MARROW FAILURE (51 patients)
PAIN (50 patients)
CYTOMEGALOVIRUS TEST POSITIVE (50 patients)
ASCITES (50 patients)
URINARY TRACT INFECTION (49 patients)
DIZZINESS (48 patients)
PRURITUS (48 patients)
MUSCULAR WEAKNESS (48 patients)
CEREBRAL HAEMORRHAGE (48 patients)
HAEMOLYTIC ANAEMIA (47 patients)
VENOOCCLUSIVE LIVER DISEASE (46 patients)
UVEITIS (46 patients)
LYMPHOCYTE COUNT DECREASED (46 patients)
DEHYDRATION (45 patients)
NEUTROPENIC SEPSIS (44 patients)
BRADYCARDIA (44 patients)
WEIGHT INCREASED (43 patients)
ARTHRALGIA (43 patients)
SYNCOPE (42 patients)
HYPERKALAEMIA (42 patients)
LEUKOPENIA (42 patients)
ATRIAL FIBRILLATION (42 patients)
ABDOMINAL DISTENSION (41 patients)
PARAESTHESIA (41 patients)
HYPERGLYCAEMIA (41 patients)
CONFUSIONAL STATE (41 patients)
PAIN IN EXTREMITY (40 patients)
RENAL DISORDER (40 patients)
JAUNDICE (39 patients)
BLOOD PRESSURE DECREASED (39 patients)
LYMPHADENOPATHY (39 patients)
CARDIO-RESPIRATORY ARREST (39 patients)
FALL (39 patients)
LUNG INFILTRATION (39 patients)
NEUROTOXICITY (38 patients)
BLOOD UREA INCREASED (38 patients)
CARDIAC ARREST (38 patients)
HYPOAESTHESIA (38 patients)
ERYTHEMA (38 patients)
LOSS OF CONSCIOUSNESS (38 patients)
PULMONARY OEDEMA (38 patients)
CHRONIC GRAFT VERSUS HOST DISEASE (37 patients)
HYPOALBUMINAEMIA (37 patients)
WEIGHT DECREASED (36 patients)
CARDIAC FAILURE CONGESTIVE (36 patients)
HYPERBILIRUBINAEMIA (36 patients)
PULMONARY HAEMORRHAGE (36 patients)
CYTOMEGALOVIRUS VIRAEMIA (36 patients)
STAPHYLOCOCCAL SEPSIS (36 patients)
DRUG ERUPTION (36 patients)
HAEMORRHAGE (35 patients)
CANDIDIASIS (35 patients)
GENERALISED OEDEMA (35 patients)
ASPERGILLOMA (35 patients)
GAIT DISTURBANCE (34 patients)
LUNG DISORDER (34 patients)
PSEUDOMONAS INFECTION (34 patients)
HEPATIC ENZYME INCREASED (33 patients)
ALOPECIA (33 patients)
DEPRESSED LEVEL OF CONSCIOUSNESS (33 patients)
PSEUDOMEMBRANOUS COLITIS (33 patients)
CYSTITIS HAEMORRHAGIC (33 patients)
GLAUCOMA (33 patients)
MUCOSAL INFLAMMATION (33 patients)
LUNG INFECTION (32 patients)
HALLUCINATION (32 patients)
PULMONARY EMBOLISM (32 patients)
POLYNEUROPATHY (32 patients)
PNEUMOCYSTIS JIROVECI PNEUMONIA (32 patients)
SOMNOLENCE (32 patients)
TREATMENT NONCOMPLIANCE (32 patients)
NO THERAPEUTIC RESPONSE (31 patients)
HYPOXIA (31 patients)
PNEUMONIA BACTERIAL (31 patients)
CHILLS (31 patients)
DRUG TOXICITY (31 patients)
TRANSPLANT REJECTION (31 patients)
PERICARDIAL EFFUSION (30 patients)
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION (30 patients)
ACUTE RESPIRATORY DISTRESS SYNDROME (30 patients)
MULTIPLE MYELOMA (30 patients)
MALIGNANT NEOPLASM PROGRESSION (30 patients)
CHEST PAIN (30 patients)
BLOOD GLUCOSE INCREASED (30 patients)
CARDIOMEGALY (30 patients)
ABASIA (29 patients)
ABDOMINAL PAIN UPPER (29 patients)
BACK PAIN (29 patients)
RHEUMATOID ARTHRITIS (29 patients)
ELECTROCARDIOGRAM QT PROLONGED (28 patients)
HAEMATURIA (28 patients)
HYPOACUSIS (28 patients)
METABOLIC ACIDOSIS (28 patients)
ELECTROLYTE IMBALANCE (28 patients)
ENCEPHALOPATHY (28 patients)
PULMONARY ALVEOLAR HAEMORRHAGE (27 patients)
PNEUMONIA FUNGAL (27 patients)
PHOTOPHOBIA (27 patients)
APLASTIC ANAEMIA (27 patients)
ATELECTASIS (27 patients)
INFLAMMATION (27 patients)
PANCREATITIS (26 patients)
TUMOUR LYSIS SYNDROME (26 patients)
CHEST DISCOMFORT (26 patients)
DEPRESSION (26 patients)
ARRHYTHMIA (26 patients)
ASTHMA (26 patients)
SYSTEMIC MYCOSIS (25 patients)
RESPIRATORY DISTRESS (25 patients)
DISEASE RECURRENCE (25 patients)
OXYGEN SATURATION DECREASED (25 patients)
AGRANULOCYTOSIS (25 patients)
WHITE BLOOD CELL COUNT INCREASED (25 patients)
DELIRIUM (25 patients)
ANOREXIA (25 patients)
OLIGURIA (25 patients)
INSOMNIA (25 patients)
BLOOD ALBUMIN DECREASED (24 patients)
TACHYCARDIA (24 patients)
THERAPEUTIC RESPONSE DECREASED (24 patients)
THROMBOTIC MICROANGIOPATHY (24 patients)
CONJUNCTIVITIS (24 patients)
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER (24 patients)
ILEUS (24 patients)
EPISTAXIS (24 patients)
OSTEONECROSIS (24 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.

Recent FactMed Activity for ITRACONAZOLE

Issue	Description / Topic	Timestamp
QUESTION CONSTIPATION	Can Itraconazole cause hard stools ?	2015-09-14 10:50:22
QUESTION CONSTIPATION	Does Itraconazole cause constipation?	2016-01-10 01:00:21
QUESTION OSTEOPOROSIS	Does itraconazole cause osteoporosis or accelerate osteopaenic suffered into the osteoporotic category?	2016-06-19 21:39:30

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about myopathy and ITRACONAZOLE, post it here. You may receive a response from a fellow patient - or a leading expert in the field.

Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking ITRACONAZOLE, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.

Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in ITRACONAZOLE. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.

We are currently accepting registration for ITRACONAZOLE experts. If you are a healthcare provider experienced in prescribing ITRACONAZOLE, please register here.